<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39426633</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Inflammatory Cytokine Responses in Pediatric tuberculosis with or without SARS-CoV-2 seropositivity.</ArticleTitle><Pagination><StartPage>106314</StartPage><MedlinePgn>106314</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2024.106314</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(24)00248-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To characterize the inflammatory cytokine profiles in children with TB in the presence and absence of SARS-CoV2 seropositivity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study evaluated cytokine responses in two groups of children with TB: CoV2+ (TB and SARS-CoV2 seropositive) and CoV2- (TB and SARS-CoV2 seronegative). Each group had 30 children, and cytokine levels were measured at baseline, month 3, and 6.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, CoV2+ children exhibited significantly elevated levels of cytokines including IFN-γ, IL-2, TNFα, IL-1α, and IL-6, and reduced levels of IL-1β and IL-18, compared to CoV2- children. No significant differences in cytokine levels between the groups were observed at months 3 and 6. Additionally, a general decline in cytokine levels was noted over the course of treatment in both groups. A positive correlation was found between most cytokines and SARS-CoV2 IgG spike protein levels at baseline and at month 3 in the CoV2+ group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study is one of the first studies to characterize the systemic inflammatory responses in SARS-CoV2 seropositive and seronegative children with TB from a TB endemic country. The findings enhance our understanding of the immunopathogenesis of TB and SARS-CoV2 seropositivity in children and may inform future therapeutic strategies.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Nathella Pavan</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India. Electronic address: nathella.pk@icmr.gov.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balaji</LastName><ForeName>Sarath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Child Health and Hospital for Children, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devi</LastName><ForeName>Poorna Ganga</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramraj</LastName><ForeName>Balaji</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nancy</LastName><ForeName>Arul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institutes of Health - International Center for Excellence in Research, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Nandhini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Institutes of Health - International Center for Excellence in Research, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahamed</LastName><ForeName>Shaik Fayaz</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S</LastName><ForeName>Suba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunasundari</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seetha</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varadarajan</LastName><ForeName>Poovazhagi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Child Health and Hospital for Children, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S</LastName><ForeName>Elilarasi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Child Health and Hospital for Children, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkataraman</LastName><ForeName>Aishwarya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ICMR - National Institute for Research in Tuberculosis, Chennai, India. Electronic address: venkataraman.a@icmr.gov.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Subash</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institutes of Health - International Center for Excellence in Research, Chennai, India; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Pediatric TB</Keyword><Keyword MajorTopicYN="N">SARS-CoV2</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39426633</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2024.106314</ArticleId><ArticleId IdType="pii">S0163-4453(24)00248-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle>